Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 473898
                    [Title] => Once-daily tablet for advanced kidney cancer approved in US
                    [Summary] => 
MANILA,  Philippines – Patients with metastatic renal cell carcinoma (mRCC) or advanced kidney cancer will soon benefit from a breakthrough therapy for this difficult-to-treat disease.
                    [DatePublished] => 2009-06-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DR. MARIE EILEEN SY

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 473898
                    [Title] => Once-daily tablet for advanced kidney cancer approved in US
                    [Summary] => 
MANILA,  Philippines – Patients with metastatic renal cell carcinoma (mRCC) or advanced kidney cancer will soon benefit from a breakthrough therapy for this difficult-to-treat disease.
                    [DatePublished] => 2009-06-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Once-daily tablet for advanced kidney cancer approved in US

June 4, 2009 - 12:00am

MANILA, Philippines – Patients with metastatic renal cell carcinoma (mRCC) or advanced kidney cancer will soon benefit from a breakthrough therapy for this difficult-to-treat disease.

Science and Environment